NDC 70771-1585-01 - NYSTATIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1585
- Requested NDC
- 70771-1585-01
- Package NDCs from labels
- 70771-1585-1, 70771-1585-3, 70771-1585-2, 70771-1585-01
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NYSTATIN - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1585-1 | NYSTATIN | 15 g in 1 BOTTLE, PLASTIC | POWDER | 15 | 5 | |
| 70771-1585-2 | NYSTATIN | 30 g in 1 BOTTLE, PLASTIC | POWDER | 30 | 5 | |
| 70771-1585-3 | NYSTATIN | 60 g in 1 BOTTLE, PLASTIC | POWDER | 60 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1585 | NYSTATIN POWDER [ZYDUS LIFESCIENCES LIMITED] | 5 | Current NDC, Legacy NDC, 3 package rows | 20241206_5d593aa9-f2e4-4adf-9f02-37832ffcb5b4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Macleods Pharmaceuticals Limited | fe3db8b2-9de4-4f9e-b763-8536a1e4cea8 | 2021-01-29 | Adverse reactions | BDF1O1C72E |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Glenmark Pharmaceuticals Inc., USA | aee696ad-9b16-42db-a6ac-49932efb9fa5 | 2020-09-21 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN OINTMENT | Proficient Rx LP | 711950c4-1889-4acd-ab76-9a16176ce1e4 | 2020-03-01 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Proficient Rx LP | 5ef15e1c-66dc-4858-8552-d83e42c3883e | 2019-11-01 | Adverse reactions | BDF1O1C72E |
| NYSTATIN | NYSTATIN | Leading Pharma, LLC | 8900ba02-2c6a-4dd4-b82f-45620c06e255 | 2019-09-19 | Adverse reactions | BDF1O1C72E |
| Nystatin Topical Powder | NYSTATIN TOPICAL POWDER | Epic Pharma, LLC | 7f313a3b-7a4c-47fb-ad9f-e267514db527 | 2018-05-02 | Adverse reactions | 646456 BDF1O1C72E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.